Skip to main content
Signal8
Launch Terminal

Pulsenmore Ltd. (PLSM)

Pulsenmore Ltd. specializes in delivering self-scanning ultrasound technology for distant medical diagnosis and health screening throughout Israel and Europe. Its primary offering is the Pulsenmore at-home ultrasound system, which consists of a portable ultrasound unit that attaches to a patient's smartphone. An accompanying mobile application then securely uploads diagnostic images to the cloud for review. Furthermore, a specialized clinician dashboard enables medical professionals to examine stored video recordings or provide real-time guidance during a scan. Founded in 2014, the company is headquartered in Omer, Israel.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

Pulsenmore Ltd. Ordinary Shares logo

Pulsenmore Ltd. Ordinary Shares

NASDAQ:PLSMHealthcare
+3.09%$1.67
Mkt Cap$12.34M
Float5.37M
O/S7.39M
Vol
$ Vol
RVOL
Inst Own4.9%
SI0.1%
Earnings
Dilution
Pulsenmore Ltd. Ordinary Shares logoNASDAQ:PLSM$1.67+3.09%
Phase Distribution
5 lead-sponsored trials·0 active·5 completed
Not applicable5
(2 more as collaborator)
Status Overview
Completed5

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Sponsor role
  • Not applicable
    Completed

    Instinct™ Ultrasound Device Safety, Efficacy and Usability

    Obstetrics Ultrasound (non invasive)

    Ultrasonography, Prenatal

    Enrollment
    100
    Start
    May 2019
    Primary Completion
    May 2020
    Completion
    Jul 2020
    NCT04399408
  • Not applicable
    Completed

    Pulsenmore ES Device, Efficacy and Safety Assessment

    Pulsenmore ES home ultrasound device

    Perinatal Care

    Enrollment
    188
    Start
    Apr 2022
    Primary Completion
    Jun 2023
    Completion
    Nov 2023
    NCT05329077
  • Not applicable
    Completed

    Self Biophysical Profile Using a Home Ultrasound Device Proof of Concept

    Pulsenmore ES home ultrasound device

    Perinatal Care

    Enrollment
    25
    Start
    Apr 2024
    Primary Completion
    Sep 2024
    Completion
    Dec 2024
    NCT06442358
  • Observational
    Completed

    Human Factoring Validation of Pulsenmore ES Device

    Pulsenmore ES home ultrasound

    Pregnancy Related

    Enrollment
    57
    Start
    Feb 2023
    Primary Completion
    Dec 2023
    Completion
    Dec 2023
    NCT06567067
  • Not applicable
    Completed

    Detection of Lung Pathologies Among Dialysis Patients Using Pulsenmore MC™ Device - Feasibility Study

    PulseNmore MC™

    Hemodialysis Patients

    Enrollment
    10
    Start
    Dec 2022
    Primary Completion
    Jun 2023
    Completion
    Dec 2023
    NCT07028060
Search ClinicalTrials.gov for “Pulsenmore”